Chief Medical Officer of Health Dr. Deena Hinshaw issued the following statement on a confirmed death linked to vaccine-induced immune thrombotic thrombocytopenia (VITT) in a patient after receiving the AstraZeneca vaccine:
“As chief medical officer of health, I am sad to report that tonight we have confirmed the death of an Alberta woman in her 50’s from VITT following vaccination from the AstraZeneca vaccine.
“Out of respect for patient confidentiality and the privacy of the grieving family, we will not be providing additional case information.
“While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine.
“The Alberta case marks the second VITT case and only death related to VITT out of more than 253,000 doses of AstraZeneca or CoviSHIELD/AstraZeneca that have been administered in Alberta to date.
“The global frequency of VITT has been estimated at approximately one case in 100,000 to 250,000 doses of vaccine. In comparison, Albertans 50 to 59 who are diagnosed with COVID-19 are 350 times more likely to die from that infection than to experience VITT after an AstraZeneca vaccine. They are also at least 1,500 times more likely to be hospitalized from COVID-19 than experiencing VITT after getting AstraZeneca.”